
United States · Nanotechnology startup
Fluid-Screen is a biotechnology and nanotechnology company founded in 2015 and based in Beverly, Massachusetts.
Funding reportedLast round: Series A
Fluid-Screen is a biotechnology and nanotechnology company founded in 2015 and based in Beverly, Massachusetts.
The company focuses on innovative bacterial detection methods, utilizing an AI-enabled lab-on-a-chip microchip system. This technology allows for the rapid detection of bacterial contamination in fluid samples, such as water, blood, and urine, achieving results in just 30 minutes with 99% accuracy. The company's primary product is a proprietary microchip that uses artificial intelligence and radio frequency waves for label-free identification of bacteria. Fluid-Screen is also developing a handheld diagnostic device that can test for bacteria and viruses in liquid samples, providing results directly to a smartphone. Their solutions cater to various industries, including pharmaceutical manufacturing, healthcare diagnostics, and water quality monitoring, significantly reducing testing times and improving safety. Fluid-Screen aims to enhance the pharmaceutical manufacturing process and contribute to global health by addressing food and water contamination.
Funding, as reported
From the SEC filings it signed: 1 on the team.
On the board, as filediDonald ZilkhaJames TylerVincent Wilczynski
What they build
Known for
bacterial detectionrapid diagnosticscontamination identificationresearch publicationscell therapywater testingreal-time detectionlabonachipenvironmental safetypathogen identificationnanotechnology researchhealthy water supplybiotherapeutics manufacturingmicrochip technologymedicalbiomanufacturing
Built with from their website
Google WorkspaceAIGoogle MeetGoDaddy DomainsAmazon AWSRemoteGustoGoDaddy HostingGoogle Search ConsoleCircle
Gmail
Add your raise, your deck and your story, and put Fluid-Screen in front of investors. Or tell us what we have wrong.